Efficacy of Zidovudine Compared to Stavudine, Both in Combination with Lamivudine and Indinavir, in Human Immunodeficiency Virus-Infected Nucleoside-Experienced Patients with No Prior Exposure to Lamivudine, Stavudine, or Protease Inhibitors (Novavir Trial)

We compared the efficacy and the toxicity of zidovudine (AZT) versus stavudine (d4T), in combination with lamivudine (3TC) and indinavir, in AZT-, dideoxyinosine (ddI)-, and/or dideoxycytosine (ddC)-experienced patients in a randomized comparative multicenter trial. One hundred seventy human immunod...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Joly, Véronique, Flandre, Philippe, Meiffredy, Vincent, Brun-Vezinet, Françoise, Gastaut, Jean-Albert, Goujard, Cécile, Remy, Gérard, Descamps, Diane, Ruffault, Annick, Certain, Agnès, Aboulker, Jean-Pierre, Yeni for the Novavir Study Group, Patrick
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2002
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC127263/
https://ncbi.nlm.nih.gov/pubmed/12019107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.6.1906-1913.2002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi